<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cancer - Lymphoma on VitaminDWiki</title><link>/categories/cancer---lymphoma.html</link><description>Recent content in Cancer - Lymphoma on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 08 Dec 2023 00:00:00 +0000</lastBuildDate><atom:link href="/categories/cancer---lymphoma/index.xml" rel="self" type="application/rss+xml"/><item><title>Lymphoma treated by Vitamin D - many studies</title><link>/posts/lymphoma-treated-by-vitamin-d-many-studies.html</link><pubDate>Fri, 08 Dec 2023 00:00:00 +0000</pubDate><guid>/posts/lymphoma-treated-by-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-is-one-of-the-lymphoma-treatments---dec-2023">Vitamin D is one of the Lymphoma treatments - Dec 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-is-one-of-the-lymphoma-treatments---dec-2023">Vitamin D is one of the Lymphoma treatments - Dec 2023&lt;/h4>
&lt;p>&lt;strong>Integrative Approaches in the Treatment of Patients Affected by Lymphoma&lt;/strong>&lt;/p>
&lt;p>Curr Oncol Rep. 2023 Dec 7. &lt;a href="https://doi.org/10.1007/s11912-023-01476-4">doi: 10.1007/s11912-023-01476-4&lt;/a>&lt;/p>
&lt;p>Ilana Levy Yurkovski 1 2 3, Francesca Andreazzoli 4, Eran Ben-Arye 5 6, Samuel Attias 7, Tamar Tadmor 8 5&lt;/p>
&lt;p>&lt;strong>Table on content&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/lymphoma-treatments.png" alt="image" width="400">
&lt;p>Purpose of review: Lymphoma is the most frequent hematological malignancy with wide disease spectrum of watchful waiting period, active treatment, survivorship, and palliative care. All these steps impose unmet needs in terms of prevention, symptom alleviation, or prognosis. Complementary and integrative medicine (CIM) is widely used by patients with lymphoma to cope with such issues. Here, we describe the different CIM modalities that may be effective and safe for the management of patients with lymphoma.&lt;/p></description></item><item><title>Non-Hodgkin’s lymphoma associated with poor Vitamin D receptor</title><link>/posts/non-hodgkins-lymphoma-associated-with-poor-vitamin-d-receptor.html</link><pubDate>Sat, 13 Feb 2021 00:00:00 +0000</pubDate><guid>/posts/non-hodgkins-lymphoma-associated-with-poor-vitamin-d-receptor.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-between-common-variants-in-vitamin-d-receptor-gene-and-susceptibility-to-non-hodgkins-lymphoma-a-case-control-study">Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin’s lymphoma: a case-control study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-between-common-variants-in-vitamin-d-receptor-gene-and-susceptibility-to-non-hodgkins-lymphoma-a-case-control-study">Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin’s lymphoma: a case-control study&lt;/h4>
&lt;p>Nucleosides, Nucleotides &amp;amp; Nucleic Acids Volume 40, 2021 - Issue 3 &lt;a href="https://doi.org/10.1080/15257770.2020.1871488">https://doi.org/10.1080/15257770.2020.1871488&lt;/a>&lt;/p>
&lt;p>Mohammad Ali Mashhadi,Narges Arbabi ,Nahid Sepehri Rad,Saman Sargazi &amp;amp;Mahdiyeh Harati-Sadegh&lt;/p>
&lt;p>Vitamin D (VDR)-mediated signaling contributes to the cell signaling pathways that affect cancer development. This study is conducted on 104 patients diagnosed with non-Hodgkin’s lymphoma (NHL) and 246 healthy subjects to investigate the link between five genetic variants spanning the VDR gene and the risk of this malignancy in Iranian subjects. The PCR-RFLP method was used for the analysis of BsmI (rs1544410), ApaI (rs7975232), FokI (rs2228570) and TaqI (rs731236) variants. A simple Tetra-ARMS-PCR technique was employed for the genotyping of the Cdx2 (rs11568820) variant. No significant link was found between both groups regarding ApaI (rs7975232) and FokI (rs2228570) variants (P &amp;gt; 0.05). Also, different genetic models of TaqI (rs731236), BsmI (rs1544410) and Cdx2 (rs11568820) polymorphisms were significantly correlated to decreased risk of NHL (Odd ratios &amp;lt;1).&lt;/p></description></item><item><title>Improved long-term chemo survival if good Vitamin D (1.8 X better - Hodgkin Lymphoma)</title><link>/posts/improved-long-term-chemo-survival-if-good-vitamin-d-18-x-better-hodgkin-lymphoma.html</link><pubDate>Tue, 22 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/improved-long-term-chemo-survival-if-good-vitamin-d-18-x-better-hodgkin-lymphoma.html</guid><description>&lt;h4 id="pretreatment-vitamin-d-deficiency-is-associated-with-impaired-progression-free-and-overall-survival-in-hodgkin-lymphoma">Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma&lt;/h4>
&lt;p>Journal of Clinical Oncology -DOI: 10.1200/JCO.19.00985&lt;/p>
&lt;p>Sven Borchmann, MD1,2,3; Melita Cirillo, MD1,4; Helen Goergen, Dipl. Math1; Lydia Meder, PhD1,2; Stephanie Sasse, MD1; Stefanie Kreissl, MD1; &amp;hellip;&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>Yet again, a study found that Chemo works much better then there is a good level of vitamin D&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;strong>&lt;a href="https://VitaminDWiki.com/Cancer+-+After+diagnosis#Cancer_-_after_diagnosis_pages_containing_CHEMO_in_title_31_as_of_Oct_2021_">Cancer - after diagnosis pages containing CHEMO in title (31 as of Oct 2021)&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Non-Hodgkin Lymphoma 20 percent more likely if low UV – meta-analysis</title><link>/posts/non-hodgkin-lymphoma-20-percent-more-likely-if-low-uv-meta-analysis.html</link><pubDate>Mon, 29 Apr 2019 00:00:00 +0000</pubDate><guid>/posts/non-hodgkin-lymphoma-20-percent-more-likely-if-low-uv-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#non-hodgkins-lymphoma-occurs-when-your-lymphocytes-dont-die">Non-Hodgkin&amp;rsquo;s lymphoma occurs when your lymphocytes don&amp;rsquo;t die&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="non-hodgkins-lymphoma-occurs-when-your-lymphocytes-dont-die">Non-Hodgkin&amp;rsquo;s lymphoma occurs when your lymphocytes don&amp;rsquo;t die&lt;/h4>
&lt;p>Normally, lymphocytes go through a predictable life cycle. Old lymphocytes die, and your body creates new ones to replace them.&lt;/p>
&lt;p>In non-Hodgkin&amp;rsquo;s lymphoma, your lymphocytes don&amp;rsquo;t die, and your body keeps creating new ones. This oversupply of lymphocytes crowds into your lymph nodes, causing them to swell. &lt;a href="https://www.mayoclinic.org/diseases-conditions/non-hodgkins-lymphoma/symptoms-causes/syc-20375680">Mayo Clinic&lt;/a>&lt;/p></description></item><item><title>Rates of some newly diagnosed Cancers increased with higher Vitamin D (217,000 Danes)</title><link>/posts/rates-of-some-newly-diagnosed-cancers-increased-with-higher-vitamin-d-217000-danes.html</link><pubDate>Tue, 08 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/rates-of-some-newly-diagnosed-cancers-increased-with-higher-vitamin-d-217000-danes.html</guid><description/></item><item><title>Lymphoid cancer deaths cut in half with 400 IU of vitamin D and 1 gram of Calcium (WHI) – RCT</title><link>/posts/lymphoid-cancer-deaths-cut-in-half-with-400-iu-of-vitamin-d-and-1-gram-of-calcium-whi-rct.html</link><pubDate>Sat, 04 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/lymphoid-cancer-deaths-cut-in-half-with-400-iu-of-vitamin-d-and-1-gram-of-calcium-whi-rct.html</guid><description/></item><item><title>Vitamin D in haematological disorders and malignancies</title><link>/posts/vitamin-d-in-haematological-disorders-and-malignancies.html</link><pubDate>Sat, 15 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-in-haematological-disorders-and-malignancies.html</guid><description>&lt;p>European Journal of haematology. Accepted manuscript online: 15 October 2016. DOI: 10.1111/ejh.12818V&lt;/p>
&lt;p>Paige M. Kulling, Kristine C. Olson, Thomas L. Olson, David J. Feith, Thomas P. Loughran Jr&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=haematological+OR+haematology&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com%20">Search VitaminDWiki for haematological OR haematology&lt;/a> 49 items as of Oct 2016&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=anemia&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for ANEMIA&lt;/a> 269 items as of Oct 2016&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/sickle-cell-vitamin-d-deficiency-corrected-with-160-k-iu-loading-dose">Sickle cell Vitamin D deficiency corrected with 160 K IU loading dose – July 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/iron-deficiency-is-a-cause-of-vitamin-d-deficiency">Iron deficiency is a cause of Vitamin D deficiency&lt;/a>&lt;/p></description></item><item><title>Cancer deaths strongly related to low vitamin D if sampled near time of diagnosis</title><link>/posts/cancer-deaths-strongly-related-to-low-vitamin-d-if-sampled-near-time-of-diagnosis.html</link><pubDate>Sat, 18 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-deaths-strongly-related-to-low-vitamin-d-if-sampled-near-time-of-diagnosis.html</guid><description>&lt;h4 id="serum-levels-of-25-hydroxyvitamin-d-and-survival-in-norwegian-patients-with-cancer-of-breast-colon-lung-and-lymphoma-a-population-based-study">Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.&lt;/h4>
&lt;p>Cancer Causes Control. 2012 Feb;23(2):363-70. &lt;a href="https://doi.org/10.1007/s10552-011-9885-6.">doi: 10.1007/s10552-011-9885-6.&lt;/a>&lt;/p>
&lt;p>Tretli S1, Schwartz GG, Torjesen PA, Robsahm TE.&lt;/p>
&lt;p>1The Cancer Registry of Norway, Institute of Population-based Cancer Research, Majorstuen, 0304 Oslo, Norway. &lt;a href="mailto:steinar.tretli@kreftregisteret.no">steinar.tretli@kreftregisteret.no&lt;/a>&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>We investigated the association between serum levels of 25-hydroxyvitamin D (25-OHD) and risk of death in Norwegian cancer patients.&lt;/p>
&lt;p>METHODS:&lt;/p></description></item><item><title>Lymphoma, leukemia etc, survival poor if low vitamin D – meta-analysis</title><link>/posts/lymphoma-leukemia-etc-survival-poor-if-low-vitamin-d-meta-analysis.html</link><pubDate>Wed, 15 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/lymphoma-leukemia-etc-survival-poor-if-low-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-levels-and-prognosis-in-hematological-malignancies-a-systematic-review-and-meta-analysis">Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis.&lt;/h4>
&lt;p>Cell Physiol Biochem. 2015 Mar 27;35(5):1999-2005. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Wang W1, Li G, He X, Gao J, Wang R, Wang Y, Zhao W.&lt;/p>
&lt;p>1Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao, China.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>Hazard Ratios for surviving hematological malignancies&lt;/p>
&lt;p>   Such as lymphoma and leukemia&lt;/p>
&lt;p>Low vitamin D (level undefined in abstract)&lt;/p>
&lt;p>Overall survival: 1.85&lt;/p></description></item><item><title>Cancer (colon, breast, lymph) survival about 2X better with high level vitamin D – meta-analysis</title><link>/posts/cancer-colon-breast-lymph-survival-about-2x-better-with-high-level-vitamin-d-meta-analysis.html</link><pubDate>Tue, 30 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-colon-breast-lymph-survival-about-2x-better-with-high-level-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="review-the-impacts-of-circulating-25-hydroxyvitamin-d-levels-on-cancer-patient-outcomes-a-systematic-review-and-meta-analysis">Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.&lt;/h4>
&lt;p>J Clin Endocrinol Metab. 2014 Jul;99(7):2327-36. &lt;a href="https://doi.org/10.1210/jc.2013-4320.">doi: 10.1210/jc.2013-4320.&lt;/a> Epub 2014 Apr 29.&lt;/p>
&lt;p>Li M1, Chen P, Li J, Chu R, Xie D, Wang H.&lt;/p>
&lt;p>CONTEXT:&lt;/p>
&lt;p>Circulating levels of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> may affect the prognosis of cancer patients; however, the epidemiological results are not consistent.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>To perform a meta-analysis of all published studies to assess the associations of circulating 25(OH)D levels measured at or near the time of diagnosis and outcomes for cancer patients.&lt;/p></description></item><item><title>Cancer survival 4 percent more likely with just a little more vitamin D (4 ng) - meta-analysis</title><link>/posts/cancer-survival-4-percent-more-likely-with-just-a-little-more-vitamin-d-4-ng-meta-analysis.html</link><pubDate>Thu, 01 May 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-survival-4-percent-more-likely-with-just-a-little-more-vitamin-d-4-ng-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-impacts-of-circulating-25-hydroxyvitamin-d-levels-on-cancer-patient-outcomes-a-systematic-review-and-meta-analysis">The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-impacts-of-circulating-25-hydroxyvitamin-d-levels-on-cancer-patient-outcomes-a-systematic-review-and-meta-analysis">The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis.&lt;/h4>
&lt;p>J Clin Endocrinol Metab. 2014 Apr 29:jc20134320.&lt;/p>
&lt;p>Li M1, Chen P, Li J, Chu R, Xie D, Wang H.&lt;/p>
&lt;p>1Key Laboratory of Food Safety Research (M.L., P.C., J.L., R.C., D.X., H.W.), Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Shanghai 200031, China; Key Laboratory of Food Safety Risk Assessment (D.X., H.W.), Ministry of Health, Beijing 100021, China; and School of Life Science and Technology (D.X., H.W.), Shanghai Tech University, Shanghai, 200031, China.&lt;/p></description></item><item><title>Inflammatory Bowel Disease and Lymphoma – associated with low vitamin D in cats too</title><link>/posts/inflammatory-bowel-disease-and-lymphoma-associated-with-low-vitamin-d-in-cats-too.html</link><pubDate>Sun, 19 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/inflammatory-bowel-disease-and-lymphoma-associated-with-low-vitamin-d-in-cats-too.html</guid><description>&lt;h4 id="cats-with-inflammatory-bowel-disease-and-intestinal-small-cell-lymphoma-have-low-serum-concentrations-of-25-hydroxyvitamin-d">Cats with Inflammatory Bowel Disease and Intestinal Small Cell Lymphoma Have Low Serum Concentrations of 25-Hydroxyvitamin D.&lt;/h4>
&lt;p>J Vet Intern Med. 2014 Jan 16. &lt;a href="https://doi.org/10.1111/jvim.12294.">doi: 10.1111/jvim.12294.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Lalor S, Schwartz AM, Titmarsh H, Reed N, Tasker S, Boland L, Berry J, Gunn-Moore D, Mellanby RJ.&lt;/p>
&lt;p>The Royal (Dick) School of Veterinary Studies, Division of Clinical Veterinary Sciences, University of Edinburgh, Edinburgh, UK.&lt;/p>
&lt;p>BACKGROUND: Inflammatory bowel disease (IBD) and intestinal small cell lymphoma (ISCL) are common diseases in cats. The prevalence of alterations in the serum concentrations of fat soluble vitamins, such as vitamin D, in cats with IBD and ISCL is unknown.&lt;/p></description></item><item><title>Molecular Link between Vitamin D and Cancer Prevention</title><link>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</guid><description>&lt;p>Nutrients 2013, 5(10), 3993-4021; doi:10.3390/nu5103993&lt;/p>
&lt;p>Meis Moukayed 1email and William B. Grant 2,* email&lt;/p>
&lt;p>1 School of Arts and Sciences, American University in Dubai, P. O. Box 28282, Dubai, UAE&lt;/p>
&lt;p>2 Sunlight, Nutrition, and Health Research Center, San Francisco, CA 94164-1603, USA&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed.&lt;/li>
&lt;/ul>
&lt;p>Received: 7 August 2013; in revised form: 11 September 2013 / Accepted: 18 September 2013 / Published: 30 September 2013&lt;/p>
&lt;p>(This article belongs to the Special Issue Vitamin D and Human Health)&lt;/p></description></item><item><title>Some childhood cancer 30% less likely in parts of California with more UVB</title><link>/posts/some-childhood-cancer-30-percent-less-likely-in-parts-of-california-with-more-uvb.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/some-childhood-cancer-30-percent-less-likely-in-parts-of-california-with-more-uvb.html</guid><description>&lt;h4 id="solar-uv-radiation-and-cancer-in-young-children">Solar UV radiation and cancer in young children&lt;/h4>
&lt;p>Christina A. Lombardi 1, Julia E. Heck 2, Myles Cockburn 3, and Beate Ritz 4,*&lt;/p>
&lt;p>1 Epidemiology, UCLA Fielding School of Public Health&lt;/p>
&lt;p>2 School of Public Health, University of California&lt;/p>
&lt;p>3 Preventive Medicine, University of Southern California&lt;/p>
&lt;p>4 UCLA Fielding School of Public Health&lt;/p>
&lt;p>↵* Corresponding Author: Beate Ritz, UCLA Fielding School of Public Health, United States &lt;a href="mailto:britz@ucla.edu">britz@ucla.edu&lt;/a>&lt;/p>
&lt;p>Background: Studies have shown that higher UV radiation exposure (UVR) may be related to lower risk of some cancers in adults. Recently an ecological study reported lower risks of some cancers among children living in higher UVR cities and countries. In a large population-based case-control study in California we tested the hypothesis that specific childhood cancers may be influenced by UVR.&lt;/p></description></item><item><title>The sun appears better at reducing incidence of some cancers than vitamin D</title><link>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</link><pubDate>Mon, 17 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</guid><description>&lt;h4 id="is-prevention-of-cancer-by-sun-exposure-more-than-just-the-effect-of-vitamin-d--a-systematic-review-of-epidemiological-studies">Is prevention of cancer by sun exposure more than just the effect of vitamin D? -A systematic review of epidemiological studies.&lt;/h4>
&lt;p>Eur J Cancer. 2012 Dec 10. pii: S0959-8049(12)00885-4. &lt;a href="https://doi.org/10.1016/j.ejca.2012.11.001.">doi: 10.1016/j.ejca.2012.11.001.&lt;/a>&lt;/p>
&lt;p>van der Rhee H, Coebergh JW, de Vries E.&lt;/p>
&lt;p>Department of Dermatology, Hagaziekenhuis, P.O. Box 40551, Leyweg 275, 2504 LN Den Haag, Zuid-Holland, The Netherlands. Electronic address: &lt;a href="mailto:hvdrhee@casema.nl">hvdrhee@casema.nl&lt;/a>.&lt;/p>
&lt;p>The number of studies reporting on the association between sunlight exposure, vitamin D and cancer risk is steadily increasing.&lt;/p></description></item><item><title>Vitamin D and Risk of Rarer Cancers</title><link>/posts/vitamin-d-and-risk-of-rarer-cancers.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-risk-of-rarer-cancers.html</guid><description>&lt;h4 id="shedding-light-on-serum-vitamin-d-concentrations-and-the-risk-of-rarer-cancers">Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers&lt;/h4>
&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.65-69 (5)&lt;/p>
&lt;p>Authors: Kathy J. Helzlsouer, Lisa Gallicchio&lt;/p>
&lt;p>Cancer is a broad term for many disparate diseases with different etiologies, commonly classified by affected organ site. This review summarizes the published evidence from prospective cohort studies examining the associations between vitamin D, measured as serum 25-hydroxyvitamin D (25OHD) concentrations, and the risk of rarer cancer sites including&lt;/p></description></item><item><title>Cancer - Lymphoma</title><link>/posts/cancer-lymphoma.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/cancer-lymphoma.html</guid><description>&lt;h4 id="ai-able-to-detect-90-of-lymphoma-sites---march-2024">AI able to detect 90% of Lymphoma sites - March 2024&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.trialsitenews.com/a/ai-detects-90-of-lymphatic-cancer-cases-introducing-lars-or-lymphoma-artificial-reader-system-6cb21bf8">TrialSiteNews&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Does not appear to mention % caught by humans&lt;/p>
&lt;hr>
&lt;h4 id="2x-more-likely-to-die-of-lymphoma-if-low-vitamin-d---meta-analysis-march-2021">2X more likely to die of lymphoma if low vitamin D - meta-analysis March 2021&lt;/h4>
&lt;p>&lt;strong>Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma&lt;/strong>&lt;/p>
&lt;p>Future Oncol. 2021 Mar 17. &lt;a href="https://doi.org/10.2217/fon-2020-0914">doi: 10.2217/fon-2020-0914&lt;/a>&lt;/p>
&lt;p>Yunxia Tao 1, Haizhu Chen 1, Yu Zhou 1, Yuankai Shi 1&lt;/p>
&lt;p>Background: This meta-analysis explored the prognostic and clinical value of serum 25-hydroxyvitamin D, 25(OH)D, levels in previously untreated lymphoma.&lt;/p></description></item><item><title>Hodgkin’s lymphoma and Vitamin D Receptor</title><link>/posts/hodgkins-lymphoma-and-vitamin-d-receptor.html</link><pubDate>Fri, 08 Jun 2012 00:00:00 +0000</pubDate><guid>/posts/hodgkins-lymphoma-and-vitamin-d-receptor.html</guid><description>&lt;h4 id="vitamin-d3-receptor-is-highly-expressed-in-hodgkins-lymphoma">Vitamin D3 receptor is highly expressed in Hodgkin’s lymphoma.&lt;/h4>
&lt;p>Christoph Renne, Alexander Benz and Martin L Hansmann&lt;/p>
&lt;p>BMC Cancer 2012, 12:215 doi:10.1186/1471-2407-12-215; Published: 6 June 2012&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Hodkin’s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure. Over a long period Vitamin D has been shown to be a potential treatment for cancer. Vitamin D acts via the vitamin D receptor, a nuclear receptor, acting as an inducible transcription factor. We aimed to investigate the expression of vitamin D receptor as potential therapeutic target structure in Hodgkin’s lymphoma as well as in non Hodgkin’s lymphoma.&lt;/p></description></item><item><title>Hours of sun per week decreased probability of NH lymphoma by 32 percent</title><link>/posts/hours-of-sun-per-week-decreased-probability-of-nh-lymphoma-by-32-percent.html</link><pubDate>Tue, 01 May 2012 00:00:00 +0000</pubDate><guid>/posts/hours-of-sun-per-week-decreased-probability-of-nh-lymphoma-by-32-percent.html</guid><description>&lt;h4 id="early-life-sun-exposure-vitamin-d-related-gene-variants-and-risk-of-non-hodgkin-lymphoma">Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.&lt;/h4>
&lt;p>Cancer Causes Control. 2012 Apr 28.&lt;/p>
&lt;p>Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE, Cerhan JR.&lt;/p>
&lt;p>School of Medicine and Dentistry, University of Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY, USA.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/early-life-sun-exposure-vitamin-d-related-gene-variants-and-risk-of-non-hodgkin-lymphoma.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Getting little UV is associated with 15 types of Cancer</title><link>/posts/getting-little-uv-is-associated-with-15-types-of-cancer.html</link><pubDate>Tue, 03 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/getting-little-uv-is-associated-with-15-types-of-cancer.html</guid><description>&lt;h3 id="ecological-studies-of-the-uvbvitamin-dcancer-hypothesis">Ecological Studies of the UVB–Vitamin D–Cancer Hypothesis&lt;/h3>
&lt;p>Anticancer Research January 2012 vol. 32 no. 1 223-236&lt;/p>
&lt;p>WILLIAM B. GRANT, Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, U.S.A. &lt;a href="mailto:wbgrant@infionline.net">wbgrant@infionline.net&lt;/a>&lt;/p>
&lt;p>Background/Aim: This paper reviews ecological studies of the ultraviolet-B (UVB)–vitamin D–cancer hypothesis based on geographical variation of cancer incidence and/or mortality rates.&lt;/p>
&lt;p>Materials and Methods: The review is based largely on three ecological studies of cancer rates from the United States; one each from Australia, China, France, Japan, and Spain; and eight multicountry, multifactorial studies of cancer incidence rates from &lt;strong>more than 100 countries&lt;/strong> .&lt;/p></description></item><item><title>Cancer patients 64% less likely to die if have high level of vitamin D</title><link>/posts/cancer-patients-64-percent-less-likely-to-die-if-have-high-level-of-vitamin-d.html</link><pubDate>Sat, 24 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/cancer-patients-64-percent-less-likely-to-die-if-have-high-level-of-vitamin-d.html</guid><description>&lt;h4 id="serum-levels-of-25-hydroxyvitamin-d-and-survival-in-norwegian-patients-with-cancer-of-breast-colon-lung-and-lymphoma-a-population-based-study">Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.&lt;/h4>
&lt;p>Cancer Causes Control. 2011 Dec 23.&lt;/p>
&lt;p>Tretli S, Schwartz GG, Torjesen PA, Robsahm TE.&lt;/p>
&lt;p>The Cancer Registry of Norway, Institute of Population-based Cancer Research, PB 5313, Majorstuen, 0304, Oslo, Norway, &lt;a href="mailto:steinar.tretli@kreftregisteret.no">steinar.tretli@kreftregisteret.no&lt;/a>.&lt;/p>
&lt;p>PURPOSE: We investigated the association between serum levels of 25-hydroxyvitamin D (25-OHD) and risk of death in Norwegian cancer patients.&lt;/p></description></item><item><title>Living in areas with more UV decreased lymph problems by 42 percent</title><link>/posts/living-in-areas-with-more-uv-decreased-lymph-problems-by-42-percent.html</link><pubDate>Fri, 12 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/living-in-areas-with-more-uv-decreased-lymph-problems-by-42-percent.html</guid><description>&lt;h1 id="adulthood-residential-ultraviolet-radiation-sun-sensitivity-dietary-vitamin-d-and-risk-of-lymphoid-malignancies-in-the-california-teachers-study">Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study&lt;/h1>
&lt;p>Ellen T. Chang1,2; Alison J. Canchola1; Myles Cockburn3; Yani Lu4; Sophia S. Wang4; Leslie Bernstein4; Christina A. Clarke1,2; and Pamela L. Horn-Ross1,2&lt;/p>
&lt;p>1 Cancer Prevention Institute of California, Fremont, CA;&lt;/p>
&lt;p>2 Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA;&lt;/p>
&lt;p>3 Division of Epidemiology, Department of Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, CA; and&lt;/p></description></item><item><title>Vitamin D Insufficiency and Prognosis in Non-Hodgkins Lymphoma</title><link>/posts/vitamin-d-insufficiency-and-prognosis-in-non-hodgkins-lymphoma.html</link><pubDate>Fri, 20 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-insufficiency-and-prognosis-in-non-hodgkins-lymphoma.html</guid><description>&lt;p>J Clin Oncol. 2010 Aug 16.&lt;/p>
&lt;p>Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, Kelly JL, Macon WR, Nowakowski GS, Inwards DJ, Johnston PB, Singh RJ, Allmer C, Slager SL, Weiner GJ, Witzig TE, Cerhan JR.&lt;/p>
&lt;p>College of Medicine, Mayo Clinic, Rochester, MN; the College of Medicine, University of Iowa, IA City, IA; and the University of Rochester, Rochester, NY.&lt;/p>
&lt;p>PURPOSE Vitamin D insufficiency is common in the United States, with low levels linked in some studies to higher cancer incidence, including non-Hodgkin&amp;rsquo;s lymphoma (NHL). Recent data also suggest that vitamin D insufficiency is related to inferior prognosis in some cancers, although there are no data for NHL.&lt;/p></description></item><item><title>Mouse Lymphoedema and vitamin D</title><link>/posts/mouse-lymphoedema-and-vitamin-d.html</link><pubDate>Tue, 22 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/mouse-lymphoedema-and-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-helped-mice-drain-skin-lymph-wonder-about-breast-cancer-lymph">Vitamin D helped mice drain skin lymph, wonder about breast cancer lymph&lt;/h1>
&lt;h2 id="topical-125-dihydroxyvitamin-d-subverts-the-priming-ability-of-draining-lymph-node-dendritic-cells">Topical 1,25-dihydroxyvitamin D subverts the priming ability of draining lymph node dendritic cells.&lt;/h2>
&lt;p>Immunology. 2010 Jun 15. Gorman S, Judge MA, Hart PH.&lt;/p>
&lt;p>Telethon Institute for Child Health Research, and Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia.&lt;/p>
&lt;p>Summary The active form of vitamin D, 1,25-hydroxyvitamin D(3) &lt;span>[1,25(OH)(2)D(3)]&lt;/span> is produced in skin following exposure to sunlight. It is also used topically to control inflammatory skin diseases by stimulating keratinocyte differentiation and suppressing immune responses. Administration of 1,25(OH)(2)D(3) to the skin of mice increases the capacity of CD4(+) CD25(+) (Foxp3(+)) regulatory T cells residing in the skin-draining lymph nodes (SDLN) to suppress immune responses. We hypothesized that dendritic cells (DC) may migrate from the skin to the lymph nodes to regulate T-cell function. Increased proportions of skin-derived DC (CD11c(+) ClassII(+) DEC-205(hi) CD8(lo)) cells were detected in the SDLN 18 hr after topical 1,25(OH)(2)D(3) treatment of mouse skin. The capacity of DC from the SDLN to take up, process and present antigen to co-cultured T cells was not modified following topical 1,25(OH)(2)D(3). However, CD11c(+) cells from the SDLN of 1,25(OH)(2)D(3)-treated mice induced a significantly smaller ear-swelling response in a T helper type 1/17-mediated model of contact hypersensitivity. CD4(+) CD25(+) cells isolated from the ear-draining lymph nodes (EDLN) of mice that received ear injections of CD11c(+) cells from donor mice topically treated with 1,25(OH)(2)D(3) more potently suppressed effector cell proliferation. In addition, EDLN cells from recipients of CD11c(+) cells from 1,25(OH)(2)D(3)-treated mice produced increased interleukin-4 levels. The CD11c(+) cells from the SDLN of mice treated with topical 1,25(OH)(2)D(3) expressed increased levels of indoleamine 2,3-dioxygenase messenger RNA, a molecule by which topical 1,25(OH)(2)D(3) may enhance the ability of DC to control the suppressive function of CD4(+) CD25(+) cells. PMID: 20561084&lt;/p></description></item></channel></rss>